Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2024.1569
Abstract: This systematic review examines the proportion and quality of postrecurrence treatment among patients in US Food and Drug Administration (FDA) registration trials of anticancer therapy in the neoadjuvant or adjuvant setting. read more here.
Keywords: fda registration; postrecurrence treatment; neoadjuvant adjuvant; registration trials ... See more keywords